Pediatric Rheumatology

Papers
(The H4-Index of Pediatric Rheumatology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches118
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey80
Proceedings of the 29th European Paediatric Rheumatology Congress43
Intravenous administration of anakinra in children with macrophage activation syndrome38
Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)36
Growth and puberty in children with juvenile idiopathic arthritis32
Distinguishing active pediatric COVID-19 pneumonia from MIS-C31
NLRP12-associated systemic autoinflammatory diseases in children27
Post SARS-CoV-2 infection reactive arthritis: a brief report of two pediatric cases26
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology24
COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?22
Pediatric rheumatology in Africa: thriving amidst challenges21
Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)20
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab19
Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East19
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature19
Systemic inflammation and chronic kidney disease in a patient due to the RNASEH2B defect17
Epidemiology of pediatric uveitis and associated systemic diseases17
Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases17
Telemedicine use by pediatric rheumatologists during the COVID-19 pandemic17
0.063752889633179